Important research outcomes for treatment studies of perinatal depression: systematic overview and development of a core outcome set.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
12 2021
Historique:
accepted: 03 05 2021
pubmed: 29 5 2021
medline: 17 12 2021
entrez: 28 5 2021
Statut: ppublish

Résumé

To develop a Core Outcome Set (COS) for treatment of perinatal depression. Systematic overview of outcomes reported in the literature and consensus development study. International. Two hundred and twenty-two participants, mainly patients, healthcare professionals and researchers, representing 13 countries. A systematic overview of outcomes reported in recently published research, a two-round Delphi survey and a consensus meeting at which the final COS was decided using modified nominal group technique. In the literature search, 1772 abstracts were identified and evaluated, and 165 studies were finally included in the review. In all, 106 outcomes were identified and included in the Delphi survey. In all, 222 participants registered for the first round of the Delphi survey and 151 (68%) responded. In the second round, 123 (55%) participants responded. Thirteen participants attended the consensus meeting, where the following nine outcomes were agreed upon for inclusion in the final COS: self-assessed symptoms of depression, diagnosis of depression by a clinician, parent to infant bonding, self-assessed symptoms of anxiety, quality of life, satisfaction with intervention, suicidal thoughts, attempted or committed suicide, thoughts of harming the baby, and adverse events. The relevant stakeholders prioritised outcomes and reached consensus on a COS comprising nine outcomes. We expect that this COS will contribute to the consistency and uniformity of outcome selection and reporting in future clinical trials involving treatment of perinatal depression. Development of a core outcome set regarding treatment for perinatal depression by @SBU_en.

Identifiants

pubmed: 34047454
doi: 10.1111/1471-0528.16780
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2141-2149

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

American Psychiatric Association. DSM-5 Task Force. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th edn. Arlington, VA: American Psychiatric Association; 2013.
Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord 2017;219:86-92.
Agnafors S, Sydsjö G, Dekeyser L, Svedin CG. Symptoms of depression postpartum and 12 years later-associations to child mental health at 12 years of age. Matern Child Health J 2013;17:405-14.
Duan C, Hare MM, Staring M, Deligiannidis KM. Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research. Int Rev Psychiatry 2019;31:264-79.
Oh Y, Joung Y-S, Baek JH, Yoo N. Maternal depression trajectories and child executive function over 9 years. J Affect Disord 2020;276:646-52.
Smith A, Twynstra J, Seabrook JA. Antenatal depression and offspring health outcomes. Obstet Med 2019;13:55-61.
Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010;303:1961-9.
Bauer A, Knapp M, Parsonage M. Lifetime costs of perinatal anxiety and depression. J Affect Disord 2016;192:83-90.
Santos H Jr, Tan X, Salomon R. Heterogeneity in perinatal depression: how far have we come? A systematic review. Arch Womens Ment Health 2017;20:11-23.
Putnam KT, Wilcox M, Robertson-Blackmore E, Sharkey K, Bergink V, Munk-Olsen T, et al. Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry 2017;4:477-85.
Wikman A, Axfors C, Iliadis SI, Cox J, Fransson E, Skalkidou A. Characteristics of women with different perinatal depression trajectories. J Neurosci Res 2020;98:1268-82.
Meltzer-Brody S. New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin Neurosci 2011;13:89-100.
Pearlstein T. Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci 2008;33:302-18.
SBU. Core Outcome Sets for Research within the Area of Maternity Care. Overview of Completed and Ongoing Studies. Stockholm, Sweden: SBU - Swedish Agency for Health Technology Assessment and Assessment of Social Services; 2020. Report no 309 [https://www.sbu.se/309e]. Accessed 8 September 2020.
Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2014;9:CD002018.
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18:280.
Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, et al. Core outcome Set-STAndards for development: the COS-STAD recommendations. PLoS Med 2017;14:e1002447.
Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, et al. Core outcome Set-STAndards for reporting: the COS-STAR statement. PLoS Med 2016;13:e1002148.
Ethical advisory opinion: Swedish Ethical Review Authority,reference dnr 2019-05673 (December 18, 2019).
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016;5:210.
Defgo.com [Internet]. Copenhagen: defgo; c2020 [cited 2020 April 1]. Available from: https://www.defgo.com/se/.
Harvey N, Holmes CA. Nominal group technique: an effective method for obtaining group consensus. Int J Nurs Pract 2012;18:188-94.
Beune IM, Ganzevoort W, Gordijn SJ. Core outcome sets are valuable, but methodological evidence can improve robustness. BJOG 2020;127:1527.
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials 2017;18:280.
Bogdanet D, Reddin C, Macken E, Griffin TP, Fhelelboom N, Biesty L, et al. Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey. Diabetologia 2019;62:2007-16.
van 't Hooft J, Duffy JMN, Daly M, Williamson PR, Meher S, Thom E, et al. A core outcome set for evaluation of interventions to prevent preterm birth. Obstet Gynecol 2016;127:49-58.

Auteurs

C Hellberg (C)

Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Stockholm, Sweden.

M Österberg (M)

Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Stockholm, Sweden.

A K Jonsson (AK)

Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Stockholm, Sweden.

S Fundell (S)

Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Stockholm, Sweden.

F Trönnberg (F)

Patient Representative, Linköping, Sweden.

M Jonsson (M)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

A Skalkidou (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH